deferasirox
- Product NDC
- 69097-393
- 11-digit product format
- 690970393
- Labeler code
- 69097
- Product ID
- 69097-393_dfe125b8-f47a-4e92-96f2-08eff47d838f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- deferasirox
- Dosage form
- TABLET, COATED
- Route
- ORAL
- Labeler
- Cipla USA Inc.
- Application
- ANDA211852
- Marketing category
- ANDA
- Marketing start
- 2020-02-13
- Marketing end
- 0000-00-00
- Substance
- DEFERASIROX
- Active strength
- 360 mg/1
- Pharmacologic classes
- Iron Chelating Activity [MoA],Iron Chelator [EPC],Cytochrome P450 3A4 Inducers [MoA],Cytochrome P450 2C8 Inhibitors [MoA],Cytochrome P450 1A2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 69097-393 | DEFERASIROX TABLET, COATED [CIPLA USA INC.] | 5 | Legacy NDC | 20211103_31df70cb-f6a0-4cba-a02c-dc9fa6bd63bd.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 69097-393-02 | 69097039302 | 30 TABLET, COATED in 1 BOTTLE (69097-393-02) | | 2020-02-13 | 0000-00-00 | No | No | Current |
| 69097-393-20 | 69097039320 | 5 BLISTER PACK in 1 CARTON (69097-393-20) > 10 TABLET, COATED in 1 BLISTER PACK (69097-393-19) | 5 blister pack | 2020-02-13 | 0000-00-00 | No | No | Current |